Atlas Trials

Absolute Bioavialability of GSK1120212

Clinical trial NCT01416337 · COMPLETED

Trial details

NCT number
NCT01416337
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2011-06-20
Primary completion
2011-12-17
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.